Drugmakers to Pool Data in Psychiatric Medication Research
Demystifying the workings of the brain have proven to be a far more daunting task for pharmaceutical companies whose bread and butter rely upon the research and development of new psychotropics. As a result, nine major pharmaceutical companies have agreed to pool data on drug trials in an effort to streamline the methodology for formulating new medications to treat psychiatric disorders. This collaboration, which unites Pfizer, AstraZeneca, Eli Lilly, Roche and others, will co-mingle findings on 67 trials regarding 11 [...]